230 related articles for article (PubMed ID: 14633602)
1. Alterations of beta-catenin pathway in non-melanoma skin tumors: loss of alpha-ABC nuclear reactivity correlates with the presence of beta-catenin gene mutation.
Doglioni C; Piccinin S; Demontis S; Cangi MG; Pecciarini L; Chiarelli C; Armellin M; Vukosavljevic T; Boiocchi M; Maestro R
Am J Pathol; 2003 Dec; 163(6):2277-87. PubMed ID: 14633602
[TBL] [Abstract][Full Text] [Related]
2. No evidence for involvement of beta-catenin and APC in urothelial carcinomas.
Stoehr R; Krieg RC; Knuechel R; Hofstaedter F; Pilarsky C; Zaak D; Schmitt R; Hartmann A
Int J Oncol; 2002 May; 20(5):905-11. PubMed ID: 11956582
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic and nuclear accumulation of beta-catenin is rarely caused by CTNNB1 exon 3 mutations in cutaneous malignant melanoma.
Omholt K; Platz A; Ringborg U; Hansson J
Int J Cancer; 2001 Jun; 92(6):839-42. PubMed ID: 11351304
[TBL] [Abstract][Full Text] [Related]
4. Frequent loss of the AXIN1 locus but absence of AXIN1 gene mutations in adenocarcinomas of the gastro-oesophageal junction with nuclear beta-catenin expression.
Koppert LB; van der Velden AW; van de Wetering M; Abbou M; van den Ouweland AM; Tilanus HW; Wijnhoven BP; Dinjens WN
Br J Cancer; 2004 Feb; 90(4):892-9. PubMed ID: 14970870
[TBL] [Abstract][Full Text] [Related]
5. Analysing the impact of nucleo-cytoplasmic shuttling of β-catenin and its antagonists APC, Axin and GSK3 on Wnt/β-catenin signalling.
Schmitz Y; Rateitschak K; Wolkenhauer O
Cell Signal; 2013 Nov; 25(11):2210-21. PubMed ID: 23872074
[TBL] [Abstract][Full Text] [Related]
6. Proliferation, but not apoptosis, is associated with distinct beta-catenin expression patterns in non-small-cell lung carcinomas: relationship with adenomatous polyposis coli and G(1)-to S-phase cell-cycle regulators.
Kotsinas A; Evangelou K; Zacharatos P; Kittas C; Gorgoulis VG
Am J Pathol; 2002 Nov; 161(5):1619-34. PubMed ID: 12414510
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas.
Ishizaki Y; Ikeda S; Fujimori M; Shimizu Y; Kurihara T; Itamoto T; Kikuchi A; Okajima M; Asahara T
Int J Oncol; 2004 May; 24(5):1077-83. PubMed ID: 15067328
[TBL] [Abstract][Full Text] [Related]
8. [Mechanism of Wnt signaling pathway regulation by a truncated mutant of Axin2 in colorectal cancer].
Wang FW; Wen L; Zhu SW; Yao Q; Cai YM; Ma G
Ai Zheng; 2007 Oct; 26(10):1041-6. PubMed ID: 17927870
[TBL] [Abstract][Full Text] [Related]
9. Low frequency of beta-catenin gene mutations in pilomatricoma.
Ha SJ; Kim JS; Seo EJ; Lee KH; Lee HJ; Kim JW
Acta Derm Venereol; 2002; 82(6):428-31. PubMed ID: 12575848
[TBL] [Abstract][Full Text] [Related]
10. Aberrant localization of beta-catenin correlates with overexpression of its target gene in human papillary thyroid cancer.
Ishigaki K; Namba H; Nakashima M; Nakayama T; Mitsutake N; Hayashi T; Maeda S; Ichinose M; Kanematsu T; Yamashita S
J Clin Endocrinol Metab; 2002 Jul; 87(7):3433-40. PubMed ID: 12107263
[TBL] [Abstract][Full Text] [Related]
11. Abnormalities of the APC/beta-catenin pathway in endometrial cancer.
Moreno-Bueno G; Hardisson D; Sánchez C; Sarrió D; Cassia R; García-Rostán G; Prat J; Guo M; Herman JG; Matías-Guiu X; Esteller M; Palacios J
Oncogene; 2002 Nov; 21(52):7981-90. PubMed ID: 12439748
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetic analysis of malignant melanomas for aberrations of the WNT signaling pathway genes CTNNB1, APC, ICAT and BTRC.
Reifenberger J; Knobbe CB; Wolter M; Blaschke B; Schulte KW; Pietsch T; Ruzicka T; Reifenberger G
Int J Cancer; 2002 Aug; 100(5):549-56. PubMed ID: 12124804
[TBL] [Abstract][Full Text] [Related]
13. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.
Wu R; Zhai Y; Fearon ER; Cho KR
Cancer Res; 2001 Nov; 61(22):8247-55. PubMed ID: 11719457
[TBL] [Abstract][Full Text] [Related]
14. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
[TBL] [Abstract][Full Text] [Related]
15. Nuclear localization and mutation of beta-catenin in medulloblastomas.
Eberhart CG; Tihan T; Burger PC
J Neuropathol Exp Neurol; 2000 Apr; 59(4):333-7. PubMed ID: 10759189
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of the beta-catenin gene in gastric carcinomas.
Sasaki Y; Morimoto I; Kusano M; Hosokawa M; Itoh F; Yanagihara K; Imai K; Tokino T
Tumour Biol; 2001; 22(2):123-30. PubMed ID: 11125285
[TBL] [Abstract][Full Text] [Related]
17. Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules.
Nakatani Y; Masudo K; Miyagi Y; Inayama Y; Kawano N; Tanaka Y; Kato K; Ito T; Kitamura H; Nagashima Y; Yamanaka S; Nakamura N; Sano J; Ogawa N; Ishiwa N; Notohara K; Resl M; Mark EJ
Mod Pathol; 2002 Jun; 15(6):617-24. PubMed ID: 12065775
[TBL] [Abstract][Full Text] [Related]
18. Frequent beta-catenin mutations in juvenile nasopharyngeal angiofibromas.
Abraham SC; Montgomery EA; Giardiello FM; Wu TT
Am J Pathol; 2001 Mar; 158(3):1073-8. PubMed ID: 11238055
[TBL] [Abstract][Full Text] [Related]
19. A common human skin tumour is caused by activating mutations in beta-catenin.
Chan EF; Gat U; McNiff JM; Fuchs E
Nat Genet; 1999 Apr; 21(4):410-3. PubMed ID: 10192393
[TBL] [Abstract][Full Text] [Related]
20. Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas.
Koch A; Hrychyk A; Hartmann W; Waha A; Mikeska T; Waha A; Schüller U; Sörensen N; Berthold F; Goodyer CG; Wiestler OD; Birchmeier W; Behrens J; Pietsch T
Int J Cancer; 2007 Jul; 121(2):284-91. PubMed ID: 17373666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
